PubRank

Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone

Clinical Trial ID NCT01450761

PubWeight™ 30.97‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01450761

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol 2013 2.64
2 Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann N Y Acad Sci 2013 2.03
3 CTLA-4 blockade in tumor models: an overview of preclinical and translational research. Cancer Immun 2013 1.71
4 What have we learned from cancer immunotherapy in the last 3 years? J Transl Med 2014 1.52
5 Immunotherapy in the treatment of non-small cell lung cancer. Lung Cancer 2014 1.35
6 Molecular pathways and therapeutic targets in lung cancer. Oncotarget 2014 1.16
7 Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes? J Thorac Oncol 2016 1.03
8 Small cell lung cancer: therapies and targets. Semin Oncol 2013 1.02
9 Clinical impact of checkpoint inhibitors as novel cancer therapies. Drugs 2014 0.99
10 Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol 2015 0.97
11 Advances in immunotherapy for treatment of lung cancer. Cancer Biol Med 2015 0.95
12 Small cell lung cancer: will recent progress lead to improved outcomes? Clin Cancer Res 2015 0.94
13 Immunotherapy for Lung Cancer: Has it Finally Arrived? Front Oncol 2014 0.94
14 Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander". Toxins (Basel) 2014 0.92
15 Immunotherapy for lung cancer: advances and prospects. Am J Clin Exp Immunol 2016 0.89
16 Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer. Invest New Drugs 2015 0.88
17 Immune checkpoint blockade: the hope for immunotherapy as a treatment of lung cancer? Semin Oncol 2013 0.87
18 Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia. J Transl Med 2013 0.85
19 Novel therapies in small cell lung cancer. Transl Lung Cancer Res 2015 0.84
20 Immunotherapy in lung cancer. Transl Lung Cancer Res 2014 0.82
21 The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment. Oncologist 2015 0.81
22 Immunotherapy in lung cancer. Transl Lung Cancer Res 2014 0.80
23 Cellular and molecular biology of small cell lung cancer: an overview. Transl Lung Cancer Res 2016 0.79
24 The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer. Oncologist 2016 0.78
25 Challenges and future perspectives of T cell immunotherapy in cancer. Immunol Lett 2015 0.78
26 Chemotherapy remains an essential element of personalized care for persons with lung cancers. Ann Oncol 2016 0.77
27 Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel? ESMO Open 2016 0.77
28 Targeted drugs in small-cell lung cancer. Transl Lung Cancer Res 2016 0.77
29 Novel therapeutic approaches for small cell lung cancer: the future has arrived. Curr Probl Cancer 2012 0.77
30 New clinical advances in immunotherapy for the treatment of solid tumours. Immunology 2015 0.76
31 Immunotherapy treatments for small-cell lung cancer: past, present and future. Lung Cancer Manag 2015 0.75
Next 100